AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ISLAND PHARMACEUTICALS LTD

0.370

0.000

Volume:95.79K

Turnover:35.52K

Market Cap:109.06M

PE:-11.74

High:0.375

Open:0.365

Low:0.365

Close:0.370

52wk High:0.630

52wk Low:0.120

Shares:294.77M

Float Shares:110.76M

Volume Ratio:0.46

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.032

EPS(LYR):-0.023

ROE:-130.31%

ROA:-74.67%

PB:15.24

PE(LYR):-16.36

Loading ...

Overview Company News Filings

Island Pharmaceuticals Secures US Patent for Antiviral Drug; Shares Rise 7%

MT Newswires Live

Island Pharmaceuticals Secures Over AU$1 Million in New Funding

MT Newswires Live

Island Pharmaceuticals Secures Membership to Medical Countermeasures Coalition, Shares Reach All-Time Peak

MT Newswires Live

Island Pharmaceuticals Says FDA Confirms Animal Rule Pathway Appropriate for Approval of Marburg Virus Countermeasures, Shares Reach All-Time Peak

MT Newswires Live

BUZZ-Australia's Island Pharmaceuticals hits record high on regulatory progress with FDA

BRIEF-Island Pharmaceuticals Seeks Trading Halt

Island Pharmaceuticals Ltd - Seeks Trading Halt Pending FDA Feedback on Galidesivir Program

THOMSON REUTERS

We're Hopeful That Island Pharmaceuticals (ASX:ILA) Will Use Its Cash Wisely

Simply Wall St.

Island Pharmaceuticals Says US FDA to Provide Feedback on Antiviral Drug Candidate Approval Pathway Next Month

MT Newswires Live

Island Pharmaceuticals Advances Galidesivir Approval With FDA Submission

MT Newswires Live

Island Pharmaceuticals Says US FDA Grants Type-C Meeting Request

MT Newswires Live

Island Pharmaceuticals Ltd: FDA Grants Island a Type C Meeting Under Galidesivir's Open Ind Application

THOMSON REUTERS

Island Pharmaceuticals Ltd: to Request Guidance on Proposed Clinical Study Design, Galidesivir's Eligibility for Priority Review Voucher

THOMSON REUTERS

Island Pharmaceuticals Ltd: Written Responses From FDA Expected by 12 Nov (US Time)

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ILA.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ILA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","market":"AU","secType":"STK","nameCN":"ISLAND PHARMACEUTICALS LTD","latestPrice":0.37,"timestamp":1774588320000,"preClose":0.37,"halted":0,"volume":95788,"delay":0,"changeRate":0,"nameEN":"ISLAND PHARMACEUTICALS LTD","floatShares":110756995,"shares":294766682,"eps":-0.031527,"marketStatus":"Market Closed","change":0,"latestTime":"03-27 16:12:00 AEDT","open":0.365,"high":0.375,"low":0.365,"amount":35516,"amplitude":0.027027,"askPrice":0.375,"askSize":21780,"bidPrice":0.365,"bidSize":47541,"shortable":3,"etf":0,"ttmEps":-0.031527,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1774825200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.37,"openAndCloseTimeList":[[1774566000000,1774587600000]],"volumeRatio":0.459037510474732,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ILA.AU","preClose":0.37,"auctionPrice":0.37,"auctionVolume":23235,"auction":3,"marketStatus":"盘后竞价","timestamp":1774588201872}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","floatShares":110756995,"roa":"-74.67%","roe":"-130.31%","lyrEps":-0.022614,"volumeRatio":0.459037510474732,"shares":294766682,"dividePrice":0,"high":0.375,"amplitude":0.027027,"preClose":0.37,"low":0.365,"week52Low":0.12,"pbRate":"15.24","psRate":"1735.27","week52High":0.63,"institutionHeld":0,"latestPrice":0.37,"committee":0.371619,"eps":-0.031527,"divideRate":0,"volume":95788,"delay":0,"ttmEps":-0.031527,"open":0.365,"prevYearClose":0.43,"prevWeekClose":0.38,"prevMonthClose":0.37,"prevQuarterClose":0.43,"fiveDayClose":0.38,"twentyDayClose":0.37,"sixtyDayClose":0.43,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ILA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ILA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ILA.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589273853","title":"Island Pharmaceuticals Secures US Patent for Antiviral Drug; Shares Rise 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589273853","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589273853?lang=en_us&edition=fundamental","pubTime":"2025-12-05 07:27","pubTimestamp":1764890854,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  received a patent from the US Patent and Trademark Office for the use of its antiviral drug, Galidesivir, in the treatment of COVID-19, according to a Friday filing with the Australian bourse.The US patent provides the company with protection to pursue treatment options for COVID-19 infections using Galidesivir until July 18, 2042, the filing said.Shares of the company rose 7% in recent Friday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ILA.AU","BK7096"],"gpt_icon":0},{"id":"2588096797","title":"Island Pharmaceuticals Secures Over AU$1 Million in New Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2588096797","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588096797?lang=en_us&edition=fundamental","pubTime":"2025-12-03 11:00","pubTimestamp":1764730846,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  has secured over AU$1 million through the exercise of 14.4 million options at AU$0.07 each by existing and substantial shareholders, according to a Wednesday Australian bourse filing.The funds will be used to drive regulatory initiatives under the US Food and Drug Administration animal rule pathway and support US government engagement to position Galidesivir for inclusion in national stockpiles as a key antiviral countermeasure, the filing added.The company's shares fell 2% in recent Wednesday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"gpt_icon":0},{"id":"2585860434","title":"Island Pharmaceuticals Secures Membership to Medical Countermeasures Coalition, Shares Reach All-Time Peak","url":"https://stock-news.laohu8.com/highlight/detail?id=2585860434","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585860434?lang=en_us&edition=fundamental","pubTime":"2025-11-24 10:06","pubTimestamp":1763949972,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  secured membership to the medical countermeasures coalition, an international coalition of non-profit organizations, academic groups, and industry partners focusing on medical countermeasures, including vaccines, therapeutics, diagnostics, and related technologies, according to a Monday Australian bourse filing.The membership is expected to help advance the firm's Galidesivir antiviral molecule program, preceding pending regulatory, clinical, and stockpiling opportunities.Its shares jumped 14% in recent trading on Monday, earlier reaching an all-time peak.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SKIS","ILA.AU","BK7096"],"gpt_icon":0},{"id":"2584163296","title":"Island Pharmaceuticals Says FDA Confirms Animal Rule Pathway Appropriate for Approval of Marburg Virus Countermeasures, Shares Reach All-Time Peak","url":"https://stock-news.laohu8.com/highlight/detail?id=2584163296","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584163296?lang=en_us&edition=fundamental","pubTime":"2025-11-17 12:26","pubTimestamp":1763353565,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  said that the US Food and Drug Administration  confirmed, in response to questions posed in a Type C meeting request, that the animal rule pathway is appropriate for the approval of Marburg virus countermeasures, and that its antiviral drug candidate Galidesivir would qualify for a tropical disease priority review voucher on approval, according to a Monday Australian bourse filing.The animal rule allows drugs to be approved based on efficacy demonstrated in well-controlled animal studies when human trials are unethical or not feasible.The regulator provided guidance on the clinical program design. The company will incorporate all the US FDA guidance into Galidesivir's clinical development pathway.The firm plans to begin the Galidesivir clinical trial program to advance approval in the first quarter of 2026. It has the opportunity to submit questions to the US FDA by Dec. 2.Its shares jumped 24% in recent trading on Monday, earlier reaching an all-time high.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SKIS","ILA.AU","BK7096"],"gpt_icon":0},{"id":"2584299615","title":"BUZZ-Australia's Island Pharmaceuticals hits record high on regulatory progress with FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2584299615","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584299615?lang=en_us&edition=fundamental","pubTime":"2025-11-17 12:05","pubTimestamp":1763352307,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Island Pharmaceuticals hits record high on regulatory progress with FDA** Shares of Australia's Island Pharmaceuticals ILA.AX rise as much as 42.4% to record high of A$0.605** Antiviral drug development co says it received positive responses from US Food & Drug Administration to questions on approval for co's antiviral drug - Galidesivir - and its eligibility for a priority review voucher ** The priority review voucher, which has historically sold on the open market for between $100 mln and $155 mln, would boost Galidesivir's commercial value - co** Co says FDA confirmed the Animal Rule pathway is appropriate for Marburg virus countermeasures, allowing approval based on animal efficacy data rather than human trials, accelerating approval timeline ** YTD, stock has more than tripled in value   ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nL6N3WT05Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILA.AU","BK7096"],"gpt_icon":0},{"id":"2583538279","title":"BRIEF-Island Pharmaceuticals Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2583538279","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583538279?lang=en_us&edition=fundamental","pubTime":"2025-11-13 09:33","pubTimestamp":1762997614,"startTime":"0","endTime":"0","summary":"BRIEF-Island Pharmaceuticals Seeks Trading HaltNov 13 (Reuters) - Island Pharmaceuticals Ltd ILA.AX:TRADING HALTSEEKS TRADING HALT PENDING FDA FEEDBACK ON GALIDESIVIR PROGRAMFurther company coverage: ILA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nTUEB7WSVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ILA.AU"],"gpt_icon":0},{"id":"2583867035","title":"Island Pharmaceuticals Ltd - Seeks Trading Halt Pending FDA Feedback on Galidesivir Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2583867035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583867035?lang=en_us&edition=fundamental","pubTime":"2025-11-13 06:12","pubTimestamp":1762985541,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUEB7WSVZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"gpt_icon":0},{"id":"2578986759","title":"We're Hopeful That Island Pharmaceuticals (ASX:ILA) Will Use Its Cash Wisely","url":"https://stock-news.laohu8.com/highlight/detail?id=2578986759","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578986759?lang=en_us&edition=fundamental","pubTime":"2025-10-28 09:44","pubTimestamp":1761615875,"startTime":"0","endTime":"0","summary":"We can readily understand why investors are attracted to unprofitable companies. Indeed, Island Pharmaceuticals...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-ila/island-pharmaceuticals-shares/news/were-hopeful-that-island-pharmaceuticals-asxila-will-use-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-ila/island-pharmaceuticals-shares/news/were-hopeful-that-island-pharmaceuticals-asxila-will-use-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ILA.AU","BK7096"],"gpt_icon":0},{"id":"2577578332","title":"Island Pharmaceuticals Says US FDA to Provide Feedback on Antiviral Drug Candidate Approval Pathway Next Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2577578332","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577578332?lang=en_us&edition=fundamental","pubTime":"2025-10-22 13:55","pubTimestamp":1761112547,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  said the US Food and Drug Administration confirmed it will provide written feedback by Nov. 12 in relation to the firm's Type C meeting to advance its antiviral drug candidate Galidesivir's approval pathway, according to a Wednesday Australian bourse filing.The firm requested guidance on the proposed study design for its upcoming non-human primate study using Galidesivir in Marburg and Galidesivir's eligibility for a priority review voucher, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"gpt_icon":0},{"id":"2571875324","title":"Island Pharmaceuticals Advances Galidesivir Approval With FDA Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2571875324","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571875324?lang=en_us&edition=fundamental","pubTime":"2025-09-29 08:23","pubTimestamp":1759105383,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  has completed submission of all briefing documents to the US Food and Drug Administration  ahead of its Type C meeting, aiming to advance the approval pathway for its antiviral drug, Galidesivir, according to a Monday filing with the Australian bourse.The meeting will center on securing FDA alignment for using the animal rule in Galidesivir's clinical development and approval, with the agency expected to provide written feedback by Nov. 12, the filing said.The submitted documents include Galidesivir's clinical history, pharmacokinetics, safety data, non-human primate study results, and rationale for the animal rule, per the filing.The company plans to finalize a strategic partnership ahead of the FDA's response to advance its Marburg animal study, targeting completion in the fourth quarter of the year, the filing added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"gpt_icon":0},{"id":"2568828213","title":"Island Pharmaceuticals Says US FDA Grants Type-C Meeting Request","url":"https://stock-news.laohu8.com/highlight/detail?id=2568828213","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568828213?lang=en_us&edition=fundamental","pubTime":"2025-09-19 08:32","pubTimestamp":1758241968,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  said the US Food and Drug Administration  has granted the company's request for a Type-C meeting regarding its clinical-stage antiviral molecule Galidesivir's open Investigational New Drug application, according to a Friday filing with the Australian bourse.In the meeting, the company will request guidance for Galidesivir's eligibility for a priority review voucher and the company's proposed clinical study design, the filing said.The FDA will provide written confirmation of the meeting by Nov. 12, the filing added.Shares of the company fell nearly 1% in recent Friday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ILA.AU","BK7096"],"gpt_icon":0},{"id":"2568811882","title":"Island Pharmaceuticals Ltd: FDA Grants Island a Type C Meeting Under Galidesivir's Open Ind Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2568811882","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568811882?lang=en_us&edition=fundamental","pubTime":"2025-09-19 07:30","pubTimestamp":1758238212,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250918:nFWN3V51BN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"gpt_icon":0},{"id":"2568811312","title":"Island Pharmaceuticals Ltd: to Request Guidance on Proposed Clinical Study Design, Galidesivir's Eligibility for Priority Review Voucher","url":"https://stock-news.laohu8.com/highlight/detail?id=2568811312","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568811312?lang=en_us&edition=fundamental","pubTime":"2025-09-19 07:30","pubTimestamp":1758238212,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250918:nFWN3V51BN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"gpt_icon":0},{"id":"2568281907","title":"Island Pharmaceuticals Ltd: Written Responses From FDA Expected by 12 Nov (US Time)","url":"https://stock-news.laohu8.com/highlight/detail?id=2568281907","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568281907?lang=en_us&edition=fundamental","pubTime":"2025-09-19 07:30","pubTimestamp":1758238212,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250918:nFWN3V51BN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":34,"code":"91000000","status":"200"}]}}